Clinical Trials Browser

Phase 4 × Has results × pegfilgrastim × Clear all

NCT03511378 2021-06-15

Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer

Phase 4 Completed

138 enrolled 13 charts

Breast Neoplasms